Omonuwa Kennedy O, Talwar Arunabh, Dedopoulos Sophy, Mailloux Lionel U
North Shore University Hospital, Department of Pulmonary, Critical Care and Sleep Medicine, Suite 107, 410 Lakeville Road, New Hyde Park, NY 11042, USA.
BMJ Case Rep. 2009;2009. doi: 10.1136/bcr.10.2008.1084. Epub 2009 Mar 20.
Patients over 10 years of age with cyanotic congenital heart disease (CCHD) risk developing significant glomerular proteinuria, a condition called cyanotic nephropathy. Even though the pathogenesis of glomerulopathy associated with CCHD is still unclear, a potential mechanism is hyperviscosity-induced decrease in peritubular capillary blood flow leading to an increase in glomerular capillary pressure, in turn resulting in proteinuria. Although angiotensin-converting enzyme (ACE) inhibitors have been traditionally used in the treatment of these patients with cyanotic nephropathy, they may, however, not be well tolerated. Here we present a case of an adult patient with CCHD who could not tolerate an ACE inhibitor but showed improvement and stabilisation of her renal function following treatment with repeated phlebotomies.
10岁以上患有紫绀型先天性心脏病(CCHD)的患者有发生显著肾小球蛋白尿的风险,这种情况称为紫绀性肾病。尽管与CCHD相关的肾小球病的发病机制仍不清楚,但一种潜在机制是高粘滞度导致肾小管周围毛细血管血流减少,进而引起肾小球毛细血管压力升高,最终导致蛋白尿。虽然传统上一直使用血管紧张素转换酶(ACE)抑制剂来治疗这些患有紫绀性肾病的患者,但他们可能耐受性不佳。在此,我们报告一例成年CCHD患者,该患者不能耐受ACE抑制剂,但在反复放血治疗后肾功能得到改善并稳定。